Association between sleep variability and time in range of glucose levels in patients with type 1 diabetes: Cross-sectional study
- PMID: 37709596
- PMCID: PMC10840618
- DOI: 10.1016/j.sleh.2023.07.007
Association between sleep variability and time in range of glucose levels in patients with type 1 diabetes: Cross-sectional study
Abstract
Objective: Sleep and circadian disturbances emerge as novel factors influencing glycemic control in type 1 diabetes (T1D). We aimed to explore the associations among sleep, behavioral circadian parameters, self-care, and glycemic parameters in T1D.
Methods: Seventy-six non-shift-working adult T1D patients participated. Blinded 7-day continuous glucose monitoring (CGM) and hemoglobin A1C (A1C) were collected. Percentages of time-in-range (glucose levels 70-180 mg/dL) and glycemic variability (measured by the coefficient of variation [%CV]) were calculated from CGM. Sleep (duration and efficiency) was recorded using 7-day actigraphy. Variability (standard deviation) of midsleep time was used to represent sleep variability. Nonparametric behavioral circadian variables were derived from actigraphy activity recordings. Self-care was measured by diabetes self-management questionnaire-revised. Multiple regression analyses were performed to identify independent predictors of glycemic parameters.
Results: Median (interquartile range) age was 34.0 (27.2, 43.1) years, 48 (63.2%) were female, and median (interquartile range) A1C was 6.8% (6.2, 7.4). Sleep duration, efficiency, and nonparametric behavioral circadian variables were not associated with glycemic parameters. After adjusting for age, sex, insulin delivery mode/CGM use, and ethnicity, each hour increase in sleep variability was associated with 9.64% less time-in-range (B = -9.64, 95% confidence interval [-16.29, -2.99], p ≤ .001). A higher diabetes self-management questionnaire score was an independent predictor of lower A1C (B = -0.18, 95% confidence interval [-0.32, -0.04]).
Conclusion: Greater sleep timing variability is independently associated with less time spent in the desirable glucose range in this T1D cohort. Reducing sleep timing variability could potentially lead to improved metabolic control and should be explored in future research.
Data availability statement: Data are available upon a reasonable request to the corresponding author.
Keywords: Continuous glucose monitor; Glycemic control; Hemoglobin A1C; Sleep; Sleep variability; Time-in-range; Type 1 diabetes.
Copyright © 2023 National Sleep Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of conflicts of interest Sirimon Reutrakul: Speaker fee from Eli Lilly. Kelly Baron: Unrestricted research gift, not applicable to this project, from Google and the National Sleep Foundation. Other authors declare no conflict of interest.
Figures


Similar articles
-
Associations between sleep characteristics and glycemic variability in youth with type 1 diabetes.Sleep Med. 2023 Sep;109:132-142. doi: 10.1016/j.sleep.2023.06.018. Epub 2023 Jun 27. Sleep Med. 2023. PMID: 37437493
-
Sleep optimization to improve glycemic control in adults with type 1 diabetes: study protocol for a randomized controlled parallel intervention trial.Trials. 2022 Aug 19;23(1):686. doi: 10.1186/s13063-022-06565-6. Trials. 2022. PMID: 35986415 Free PMC article.
-
The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.Diabetes Care. 2020 Oct;43(10):2349-2354. doi: 10.2337/dc20-0016. Epub 2020 May 27. Diabetes Care. 2020. PMID: 32461211 Free PMC article.
-
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236. doi: 10.1210/clinem/dgac034. J Clin Endocrinol Metab. 2022. PMID: 35094087 Free PMC article. Review.
-
Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?Nephron. 2023;147(2):91-96. doi: 10.1159/000525676. Epub 2022 Jul 13. Nephron. 2023. PMID: 35830847 Review.
Cited by
-
Sleep Irregularity, Circadian Disruption, and Cardiometabolic Disease Risk.Circ Res. 2025 Aug 15;137(5):709-726. doi: 10.1161/CIRCRESAHA.125.325613. Epub 2025 Aug 14. Circ Res. 2025. PMID: 40811504 Review.
-
Sleep Health Composite and Diabetes Symptom Burden in Young Adults With Type 1 Diabetes.West J Nurs Res. 2024 Nov;46(11):919-927. doi: 10.1177/01939459241287455. Epub 2024 Sep 30. West J Nurs Res. 2024. PMID: 39345102
-
Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk.J Clin Endocrinol Metab. 2024 Nov 18;109(12):3011-3026. doi: 10.1210/clinem/dgae539. J Clin Endocrinol Metab. 2024. PMID: 39106222 Free PMC article. Review.
References
-
- Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589–625. - PubMed
-
- DeSalvo DJ, Noor N, Xie C, Corathers SD, Majidi S, McDonough RJ, et al. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study. Journal of diabetes science and technology. 2021:19322968211049783. - PMC - PubMed
-
- Zhu B, Abu Irsheed GM, Martyn-Nemeth P, Reutrakul S. Type 1 Diabetes, Sleep, and Hypoglycemia. Current diabetes reports. 2021;21(12):55. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical